Citalopram: When a Familiar SSRI Requires Attention to the Heart
Author: The Narcis editorial team · updated: August 2026
🩺 Medical review: awaiting confirmation by a medical reviewer · psychiatrist
Prepared by the Narcis editorial team. The author is a practising psychotherapist, not a physician. This is a review of official prescribing information and clinical guidelines, not a medical opinion: every source below is open and every claim can be checked.
This article explains how a medicine works and what research says about it. Dosing schedules are deliberately omitted. Only a doctor — a psychiatrist or GP — prescribes, changes or stops medication. Narcis is a psychotherapy platform and does not prescribe. Never start or stop a medicine based on an article: for some drugs, abrupt discontinuation is more dangerous than continuing. Approved indications for the same drug differ between countries.
Do not wait for the medicine to “kick in” if you notice:
a sharp worsening of your state · thoughts of self-harm · unusual agitation or signs of mania or hypomania · seizures · confusion · a severe allergic reaction. Seek medical help immediately. Where to turn →
Citalopram is a classic SSRI officially used for major depressive disorder in adults. Its profile seems straightforward, but one feature makes the idea “more dose equals more benefit” particularly problematic: dose-dependent QT-interval prolongation on ECG.
What changes the picture
Official labeling warns about QTc prolongation and the risk of serious ventricular arrhythmias. This is why maximum-dose restrictions and extra caution apply in people with congenital long QT, bradycardia, low potassium or magnesium, heart failure, or combinations with other QT-prolonging drugs.
That does not mean every person needs an extensive cardiac work-up before one tablet. It means the clinician needs to know the cardiac history, other medications, and relevant risk factors. Sometimes a seemingly routine medication list is exactly what changes the antidepressant choice.
Other possible effects are familiar from the SSRI class: nausea, sleep changes, sexual dysfunction, serotonin-syndrome risk with unsafe combinations, and withdrawal symptoms after abrupt discontinuation. The manufacturer recommends gradual dose reduction.
Dose studies illustrate a broader principle: increasing an antidepressant dose does not always produce additional benefit, while some risks may rise. Psychopharmacology is full of situations in which “more” does not automatically mean “better.”
Citalopram remains a useful antidepressant. Its distinctive issue is not a mysterious psychiatric effect, but a concrete and well-described cardiac safety consideration that deserves attention.
When the pattern becomes visible
A person with cardiac risk factors reads about citalopram and assumes all SSRIs are interchangeable. This shows why prescribing cannot be reduced to popularity lists: citalopram has a dose-related QT consideration that may be irrelevant for one patient and important for another.
An important clinical qualification
Average efficacy in research does not guarantee an individual outcome. Here, population-level evidence and one patient’s experience are different levels of information: a well-supported medication may not fit one person, while another may benefit greatly despite an average trade-off profile.
What therapy can — and cannot — do
Psychotherapy and medication are not competitors. Here, therapy may address avoidance, catastrophic interpretations, behavioral cycles, relationships, and regulation skills, while medication targets biological aspects of the condition. The balance depends on diagnosis, severity, previous treatment, and patient preference.
What to observe over a week
For a prescriber conversation about “this topic,” bring your own data rather than an internet ranking: the target symptom, when it began, what has already been tried, other medicines and medical conditions, and which adverse effects would be especially difficult for you. After starting treatment, track changes in sleep, anxiety, mood, functioning, and side effects over time. Sudden deterioration, suicidal thoughts, marked agitation, signs of mania, an allergic reaction, or another acute symptom require prompt medical contact or emergency care. Do not change the dose or discontinue a prescription medicine on the basis of an article.
Medical note. Important: comparisons in this article are not individualized prescribing advice. Effectiveness and tolerability depend on diagnosis, comorbidities, other medicines, prior response, and individual risks.
Books and sources
• DailyMed: Citalopram — official prescribing information
• DailyMed: Citalopram — clinical studies and QT warning
• NICE CG113 — SSRI safety considerations
If this topic resonated — you do not have to sit with it alone.
Therapy can be part of comprehensive care — find a specialist →Sources checked: August 2026. Guidelines and prescribing information change over time — if this article is old, check the original via the link.
This article is for information only and is not a substitute for an individual consultation with a specialist.